Company Name:Moderna, Inc.
CEO: St├ęphane Bancel

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.


Key numbers

Market Capitalization:30915396240
Shares Outstanding: 388824000
Float: 307856068
Next Earning Date:
TTm EPS: -1.5061
TTm Dividend Rate:
200 days moving average:36.74
50 days moving average: 66.91
One day percent Change: 5.24



2017-12-31, 2018-09-30, 2018-12-31,
2017-12-31, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,